Comparison of Histopathologic Features of Endometrial Cancer Based on Menopausal Status and Safety of Ovarian Preservation in Premenopausal Women

  • Ozgur Kan Mail Deparment of Obstetrics and Gynecology, Ankara University, Ankara, Turkey.
  • Aysegul Alkilic Deparment of Obstetrics and Gynecology, Ankara University, Ankara, Turkey.
  • Elif Nazlı Cetindag Aydın Deparment of Obstetrics and Gynecology, Ankara University, Ankara, Turkey.
  • Kazibe Koyuncu Deparment of Obstetrics and Gynecology, Ankara University, Ankara, Turkey.
  • Salih Taskin Deparment of Obstetrics and Gynecology, Ankara University, Ankara, Turkey.
  • Firat Ortac Deparment of Obstetrics and Gynecology, Ankara University, Ankara, Turkey.
Keywords:
Endometrial cancer, Ovarian preservation, Coexisting malignancy, Premenopausal women

Abstract

The aim of this study was to investigate the frequency of coexisting ovarian malignancy and to determine whether ovarian preservation is feasible in premenopausal endometrial cancer (EC) patients. The data of 251 patients with endometrioid type endometrial cancer were retrospectively reviewed. We classified patients into two groups based on menopausal status. Information regarding patient age, preoperative and intraoperative evaluations, pathology reports, and follow-up results were abstracted from medical records. Coexisting ovarian malignancy was detected in 2 (4.3%) of 46 patients in premenopausal group and in 11 (5.3%) of 205 patients in postmenopausal group. Both patients in premenopausal group with coexisting ovarian malignancy had lymph node involvement and grade 2 tumors, while 5 (45.4%) of 11 patients in postmenopausal group had lymph node involvement and 9 (81.8%) of 11 patients had grade 3 tumors. Incidence of coexisting ovarian malignancies in premenopausal women with EC should not be underestimated. Owing to that thorough preoperative evaluation and an extensive intraoperative evaluation is critical for the decision of preserving ovaries.

References

Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10–29.

Creasman WT, et al. Carcinoma of the corpus uteri. J Epidemiol Biostat 2001; 6(1): 47–86.

Lee NK, Cheung MK, Shin JY, et al: Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol 109:655-662, 2007

Tran BN, Connell PP, Waggoner S, et al: Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol 23:476-480, 2000

Creasman WT, Morrow PC, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987; 60(8 suppl): 2035-2041.

Gemer O, Bergman M, Segal S. Ovarian metastasis in women with clinical stage І endometrial carcinoma. Acta Obstet Gynecol Scand. 2004; 83(2): 208-210.

Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol. 2005; 106:693–9.

Koskas M, Bendifallah S, Luton D, Darai E, Rouzier R. Safety of uterine and/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to the extent of surgery. Fertil Steril 2012; 98:1229–35.

Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol 2009; 27:1214-9.

Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol. 1985; 16: 28–34.

Lin KY, Miller DS, Bailey AA, Andrews SJ, Kehoe SM, Richardson DL, Lea JS. Ovarian involvement in endometrioid adenocarcinoma of uterus. Gynecol Oncol 2015; 138: 532–535

Gitsch G, Hanzal E, Jensen D, Hacker NF. Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol 1995; 85:504–8.

Lee TS, Jung JY, Kim JW, Park NH, Song YS, Kang SB, et al. Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol Oncol 2007; 104:52–7.

Shamshirsaz AA, Withiam-Leitch M, Odunsi K, Baker T, Frederick PJ, Lele S. Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review. Gynecol Oncol 2007; 104:757–60.

Yamazawa K, Seki K, Matsui H, Kihara M, Sekiya S. Prognostic factors in young women with endometrial carcinoma: a report of 20 cases and review of literature. Int J Gynecol Cancer. 2000; 10(3): 212-222.

Evans-Metcalf ER, Brooks SE, Reale FR, Baker SP. Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol. 1998; 91(3): 349-54.

Pan Z, Wang X, Zhang X, Chen X, Xie X. Retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage I endometrial carcinoma. J Obstet Gynaecol Res 2011; 37:352–8.

Akbayir O, Kuru O, Goksedef P, Numanoglu C, Corbacioglu A, Cetin A. Coexisting ovarian malignancy in patients with clinical stage I endometrial carcinoma. Arch Gynecol Obstet 2012; 286:1241–5.

Published
2017-07-11
How to Cite
1.
Kan O, Alkilic A, Cetindag Aydın EN, Koyuncu K, Taskin S, Ortac F. Comparison of Histopathologic Features of Endometrial Cancer Based on Menopausal Status and Safety of Ovarian Preservation in Premenopausal Women. Acta Med Iran. 55(5):311-315.
Section
Articles